Cellprothera Sas Is A Biotechnology Company Based In Mulhousefrancespecializing In Regenerative Medicine With A Strong Emphasis On Stem Cell Therapieswith Over 15 Years Of Experience In Innovative Research And Developmentthe Company Is At The Forefront Of Cardiac Regenerative Therapyutilizing Autologous Cell Therapy To Harness Patientsown Stem Cells For Personalized Treatment The Company Has Developed Protheracytesa Closed Automated Technology For Expanding Cd34Cellswhich Are Crucial For Revascularizing Ischemic Lesionsparticularly After Myocardial Infarctioncellprothera Also Engages In Research Across Various Therapeutic Areasincluding Cardiologyoncologyhematologyand Immunologytheir Services Include Co Development Partnershipsclinical Researchand Technologies For Cell Banking And Expansionwith A Focus On Advancing Its Therapeutic Productscellprothera Is Actively Involved In Clinical Trials And Has A Diverse Drug Pipeline Targeting Conditions Such As Refractory Angina And Knee Osteoarthritis
